Showing results 34 to 71 of 71
< previous
Issue Date | Title | Author(s) |
2006 | High-dose quetiapine and photopsia | Hazra, Monica; Culo, Sandi; Mamo, David |
2011 | Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis | Fuente-Sandoval, Camilo de la; Leon-Ortiz, Pablo; Favila, Rafael; Stephano, Sylvana; Mamo, David; Ramirez-Bermudez, Jesus; Graff-Guerrero, Ariel |
2013 | Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia : analysis of the CATIE data | Tsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel; Mimura, Masaru; Uchida, Hiroyuki |
2015 | Illness denial in schizophrenia spectrum disorders : a function of left hemisphere dominance | Gerretsen, Philip; Menon, Mahesh; Chakravarty, M. Mallar; Lerch, Jason P.; Mamo, David; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel |
2022 | The impact and management SARS-CoV-2 in a psychiatric hospital setting | Warwicker, Sean; Piscopo, Naomi; Duca, Kristina; Baldacchino, Gabriella; Camilleri, Jean; Caruana, Luke; Grech, Anton; Mamo, David |
2011 | Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia | Hazra, Monica; Uchida, Hiroyuki; Sproule, Beth A.; Remington, Gary; Suzuki, Takefumi; Mamo, David |
2014 | Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders : resting state functional connectivity | Gerretsen, Philip; Menon, Mahesh; Mamo, David; Fervaha, Gagan; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel |
2009 | An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18 F] FP-TZTP | van Oosten, Erik M.; Wilson, Alan A.; Stephenson, Karin A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Yudin, Andrei K.; Houle, Sylvain; Vasdev, Neil |
2008 | The inclusion of intellectually and/or physically challenged pupil during the physical education lesson : a case study | Mamo, David |
2009 | The intersection of pharmacology, imaging, and genetics in the development of personalized medicine | Gerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G. |
2010 | Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [18F] setoperone PET study | Gerretsen, Philip; Graff-Guerrero, Ariel; Menon, Mahesh; Pollock, Bruce G.; Kapur, Shitij; Vasdev, Neil; Houle, Sylvain; Mamo, David |
2015 | Lack of age-dependent decrease in dopamine D3 receptor availability : a [11C]-(+)-PHNO and [11C]-raclopride positron emission tomography study | Nakajima, Shinichiro; Caravaggio, Fernando; Boileau, Isabelle; Chung, Jun Ku; Plitman, Eric; Gerretsen, Philip; Wilson, Alan A.; Houle, Sylvain; Mamo, David; Graff-Guerrero, Ariel |
2016 | Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia : a positron emission tomography dopamine D2/3 receptor occupancy study | Fervaha, Gagan; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Pollock, Bruce G.; Nakajima, Shinichiro; Gerretsen, Philip; Rajji, Tarek K.; Mar, Wanna; Iwata, Yusuke; Plitman, Eric; Chung, Jun Ku; Remington, Gary; Graff-Guerrero, Ariel |
2017 | ‘Let me win’ : narrative of an intellectually disabled person participating in competitive sport | Mamo, David |
2009 | Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychotics | Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David |
2009 | Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia : meta-analysis | Uchida, Hiroyuki; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Arenovich, Tamara; Mamo, David |
2011 | Management of schizophrenia in late life with antipsychotic medications | Suzuki, Takefumi; Remington, Gary; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mamo, David |
2007 | Managing suicidality in schizophrenia | Mamo, David |
2019 | National strategic policy for active ageing | Formosa, Marvin; Abela, Stephen; Cachia, Joseph; Lungaro-Mifsud, Stephen; Mamo, David; Rapa, Josephine; Scerri, Anthony; Schembri, Tracey; Xuereb, Stephanie |
2011 | Neurobiology of delusions in Alzheimer’s disease | Ismail, Zahinoor; Nguyen, Minh-Quan; Fischer, Corinne E.; Schweizer, Tom A.; Mulsant, Benoit H.; Mamo, David |
2006 | A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone | Remington, Gary; Mamo, David; Labelle, Alain; Reiss, Jeffrey; Shammi, Chekkera M.; Mannaert, Erik; Mann, Steve; Kapur, Shitij |
2004 | A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone | Mamo, David; Kapur, Shitij; Shammi, Chekkera M.; Papatheodorou, George; Mann, Steve; Therrien, Francois; Remington, Gary |
2009 | Predicting age‐specific dosing of antipsychotics | Uchida, Hiroyuki; Pollock, Bruce G.; Bies, Robert R.; Mamo, David |
2012 | Predicting hospital length of stay for geriatric patients with mood disorders | Ismail, Zahinoor; Arenovich, Tamara; Grieve, Charlotte; Willett, Peggie; Sajeev, Gautam; Mamo, David; MacQueen, Glenda M.; Mulsant, Benoit H. |
2012 | Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic study | Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R. |
2015 | Predicting plasma olanzapine concentration following a change in dosage : a population pharmacokinetic study | Tsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Nakajima, Shinichiro; Graff-Guerrero, Ariel; Mamo, David; Caravaggio, Fernando; Plitman, Eric; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki |
2007 | Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection | Odontiadis, John; MacKenzie, Erin M.; Natesan, Sridhar; Mamo, David; Kapur, Shitij; Baker, Glen B. |
2009 | The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics | Mizrahi, Romina; Mamo, David; Rusjan, Pablo; Graff, Ariel; Houle, Sylvain; Kapur, Shitij |
2010 | Sensitivity to antipsychotic drugs in older adults | Leon, Chloe; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Rajji, Tarek K.; Mamo, David |
2007 | Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response - a double-blind PET study in schizophrenia | Agid, Ofer; Mamo, David; Ginovart, Nathalie; Vitcu, Irina; Wilson, Alan A.; Zipursky, Robert B.; Kapur, Shitij |
2009 | Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan | Uchida, Hiroyuki; Suzuki, Takefumi; Mamo, David; Mulsant, Benoit H.; Tsunoda, Kenichi; Takeuchi, Hiroyoshi; Kikuchi, Toshiaki; Nakajima, Shinichiro; Nomura, Kensuke; Tomita, Masayuki; Watanabe, Koichiro; Kashima, Haruo |
2009 | Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT 2A) receptors in older, healthy adults | Chow, Tiffany W.; Mamo, David; Uchida, Hiroyuki; Graff- Guerrero, Ariel; Houle, Sylvain; Smith, Gwenn S.; Pollock, Bruce G.; Mulsant, Benoit H. |
2011 | Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia | Suzuki, Takefumi; Remington, Gary; Arenovich, Tamara; Uchida, Hiroyuki; Agid, Ofer; Graff-Guerrero, Ariel; Mamo, David |
2010 | Towards the development of new subtype-specific muscarinic receptor radiopharmaceuticals-radiosynthesis and ex vivo biodistribution of [18F] 3-(4-(2-(2-(2-fluoroethoxy) ethoxy) ethylthio)-1, 2, 5-thiadiazol-3-yl)-1-methyl-1, 2, 5, 6-tetrahydropyridine | van Oosten, Erik M.; Wilson, Alan A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Houle, Sylvain; Vasdev, Neil |
2011 | Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia : a case report and systematic literature review | Gerretsen, Philip; Diaz, Pablo; Mamo, David; Kavanagh, Doug; Menon, Mahesh; Pollock, Bruce G.; Graff-Guerrero, Ariel |
2011 | Treatment resistant schizophrenia and response to antipsychotics : a review | Suzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Rajji, Tarek K.; Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mamo, David |
2014 | The VAGUS insight into psychosis scale-self-report and clinician-rated versions | Gerretsen, Philip; Remington, Gary; Borlido, Carol; Quilty, Lena; Hassan, Sabrina; Polsinelli, Gina; Teo, Celine; Mar, Wanna; Simon, Regina; Menon, Mahesh; Pothier, David D.; Nakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Rajji, Tarek K.; Mulsant, Benoit H.; Deluca, Vincenzo; Ganguli, Rohan; Pollock, Bruce G.; Graff-Guerrero, Ariel |
2017 | Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders | Gerretsen, Philip; Pothier, David D.; Falls, Carolyn; Armstrong, Maxine; Balakumar, Thushanthi; Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel |